Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

102
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
102
Nursing Assessment of the Genitourinary System II: Inspection and Palpation01:26

Nursing Assessment of the Genitourinary System II: Inspection and Palpation

282
The nursing assessment of the genitourinary (GU) system involves a systematic inspection and palpation to identify abnormalities in the kidneys, bladder, and surrounding structures.InspectionMouth: Inspect for signs of kidney dysfunction, such as stomatitis (inflammation of the mouth) and ammonia breath, which may occur in advanced kidney disease due to the buildup of urea, breaking down into ammonia.Skin: Check for pallor, which could indicate anemia caused by kidney disease. Look for...
282
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

148
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
148
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

139
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
139
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

77
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
77

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of quality of life and social participation in myotonic dystrophy type 1.

Revue neurologique·2025
Same author

Description of peripheral nervous system involvement in wild-type transthyretin amyloidosis: A clinical and electrophysiological study.

Revue neurologique·2025
Same author

French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

Revue neurologique·2025
Same author

Postural balance and visual dependence in patients with demyelinating neuropathies differ between acquired and hereditary etiologies.

Revue neurologique·2024
Same author

RFC1: Motifs and phenotypes.

Revue neurologique·2024
Same author

Seizure recurrences in generalized convulsive status epilepticus under sedation: What are its predictors and its impact on outcome?

Revue neurologique·2023

Related Experiment Video

Updated: Oct 7, 2025

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

81.8K

Intensive care unit-acquired weakness: Questions the clinician should ask.

R Tortuyaux1, J-B Davion2, M Jourdain3

  • 1CHU de Lille, médecine intensive-réanimation, 59000 Lille, France; CHU de Lille, department of clinical neurophysiology, 59000 Lille, France.

Revue Neurologique
|January 9, 2022
PubMed
Summary

Intensive care unit (ICU)-acquired weakness (ICU-AW) is a common complication in critically ill patients. Early identification and prevention by minimizing sedation and immobility are crucial for improving outcomes and reducing mortality.

Keywords:
Critical illness polyneuropathyDelayed weaningICU-acquired weaknessIllness severityNeurophysiology

More Related Videos

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.7K
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

741

Related Experiment Videos

Last Updated: Oct 7, 2025

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

81.8K
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.7K
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

741

Area of Science:

  • Critical care medicine
  • Neurology
  • Intensive care unit (ICU) patient management

Background:

  • Intensive care unit (ICU)-acquired weakness (ICU-AW) is common in critically ill patients.
  • It is characterized by weakness with no cause other than critical illness itself.
  • ICU-AW encompasses critical illness polyneuropathy, myopathy, and neuromyopathy.

Purpose of the Study:

  • To provide clinicians with practical questions for diagnosing and managing ICU-AW.
  • To review risk factors, diagnostic methods, prognosis, and recovery strategies for ICU-AW.
  • To emphasize preventive measures for ICU-AW.

Main Methods:

  • Literature review on ICU-acquired weakness.
  • Electrophysiological classification of ICU-AW subtypes.
  • Analysis of risk factors, management, and outcomes.

Main Results:

  • ICU-AW is frequent, associated with illness severity, organ failure, age, hyperglycemia, and immobility.
  • It leads to prolonged hospitalization and increased mortality.
  • Preventive strategies, particularly limiting sedation and immobilization, are key.

Conclusions:

  • Management focuses on preventing modifiable risk factors like sedation and immobility.
  • Pharmacological treatments have not demonstrated efficacy.
  • Early suspicion, diagnosis, and management are vital for patient recovery.